ID: MRFR/HC/6539-HCR | 90 Pages | Author: Rahul Gotadki | May 2023
The Craniomaxillofacial (CMF) Devices Market is expected to grow USD 4,239.37 million to register a CAGR of 9.40% from 2020-2030.
The Craniomaxillofacial (CMF) Devices Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 4,239.37 million in 2020 and is projected to register a CAGR of 9.40% over the forecast 2020-2030.
The increasing participation of key players is one of the key factors driving the craniomaxillofacial (CMF) devices market. In 2019, Kelyniam Global (KLYG) received premarket FDA approval for unique modifications to their PEEK cranio-maxillofacial implant product line.
Various other factors such as the acceptance of craniomaxillofacial (CMF) devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and growing demand for bioresorbable devices are also expected to propel the growth of the Craniomaxillofacial (CMF) Devices Market.
However, the low success rate of surgical procedures, and high costs and shortcomings of titanium implants can hamper craniomaxillofacial (CMF) devices market growth over the forecast period.
The craniomaxillofacial devices market is segmented based on product, material, application, end user, and region.
The global craniomaxillofacial (CMF) devices market, by product, is segmented into cranial flap fixation, craniomaxillofacial fixation (CMF) distraction, temporomandibular joint replacement
thoracic fixation, bone graft substitute, CMF plate and screw fixation, and dural repair. The dural repair segment is further classified as dural sealants and dural substitutes.
Based on material, the Craniomaxillofacial (CMF) Devices market is segmented into metals and alloys, bioabsorbable, ceramics, polymers, and others.
Based on application, the Craniomaxillofacial (CMF) Devices market is segmented into neurosurgery, ENT, orthognathic & dental surgery, plastic surgery, and others.
Based on end user, the Craniomaxillofacial (CMF) Devices market is segmented into hospitals, ambulatory surgical centers, and others.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The craniomaxillofacial devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European craniomaxillofacial devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The craniomaxillofacial devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The craniomaxillofacial devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Craniomaxillofacial (CMF) Devices Market Share (%), by Region, 2017
Sources: MRFR Analysis
The Americas dominated the global market for CMF devices owing to the rising number of craniofacial surgeons within the region. As per the 2017 data published in the Journal of Surgical Education, the number of craniofacial surgery fellowship graduates were increasing. It was reported that around 175 craniofacial surgeons were trained at 35 fellowship programs in 2017. Rising participation of market players is also strongly impacting the growth of the Americas craniomaxillofacial (CMF) devices market. For instance, in 2016, the US- and Brazil-based company, BioArchitects received FDA approval for 3D-printed titanium cranial/maxillofacial implant. This 3D Printing uses electron beam melting technology, which involves using electron beams to melt and fuse very fine metal powder.
In 2018, it was estimated that Europe stood second in the global Craniomaxillofacial (CMF) Devices market. Technological advancements, along with the availability of funding opportunities in research and innovation, will support market growth.
Asia-Pacific (APAC) is expected to represent the phenomenal CMF devices market growth throughout the forecast period due to rising prevalence of chronic conditions, growing awareness about CMF devices, and rising demand for minimally invasive surgeries. The population in developing economies is focusing towards minimally invasive procedures to treat a variety of medical and aesthetic imperfections.
On the other hand, the Middle East and Africa held the least share in the global CMF devices market due to the low economic development, especially within the African region.
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research ( 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
Craniomaxillofacial (CMF) Devices Market, by Product
Craniomaxillofacial (CMF) Devices Market, by Material
Craniomaxillofacial (CMF) Devices Market, by Application
Craniomaxillofacial (CMF) Devices Market, by End User
|Market Size||2030: USD 4,239.37 million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Material, Application, End user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Aesculap Implant System LLp, Integra Lifesciences Corporation, Johnson & Johnson, Kanghui Orthopedic, KLS Martin, MATRIX SURGICAL USA, Medartis AG, Medtronic, OsteoMed, Stryker Corporation, TMJ Concepts, L. Gore and Associates|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
The Craniomaxillofacial (CMF) devices market is slated to grow with 9.40% CAGR during the forecast period of 2020 to 2030.
The prime factor to drive the Craniomaxillofacial (CMF) devices market growth is the increasing participation from various market players.
Low success rate, high cost, and problems with titanium implants can deter the Craniomaxillofacial (CMF) devices market growth.
The Americas would lead the global Craniomaxillofacial (CMF) devices market.
The Asia Pacific would be the top of the global Craniomaxillofacial (CMF) devices market in terms of growth rate.
Key Questions Answered
Why Choose Market Research Future?